Sign Up Today and Learn More About Cota Healthcare Stock
Invest in or calculate the value of your shares in Cota Healthcare or other pre-IPO companies through EquityZen's platform.
Cota Healthcare Stock (COHE)
Cota builds solutions for healthcare to analyze, visualize, report, and manage real-world evidence and deliver precision medicine.
About Cota Healthcare Stock
Founded
2011
Headquarters
New York, NY, US
Total Funding
65.0M
Industries
Software, Artificial Intelligence, Data and Analytics
Cota empowers healthcare professionals with data and technology solutions to deliver value-based precision medicine. Cota is a technology platform that enables providers, payers, and life science companies to make value-based decisions with real-world evidence about diagnosing and treating complex diseases. Beginning with oncology and now expanding into behavioral health and chronic medical conditions, Cota enriches raw medical records to create research-grade clinical data, classifies each patient and their disease in a uniquely powerful way using a patented methodology, and combines this cohorted patient data with cost data. Use of Cota enables providers to improve individual patient clinical outcomes and lower the total cost of care of the population served. Cota also enables life sciences companies to accelerate clinical development, and academics and advocacy organizations to accelerate research, all via an easy-to-use web-based interface.
Cota Healthcare Press Mentions
Stay in the know about the latest news on Cota Healthcare
PreciseDx's digital pathology AI on par with genomic testing in predicting breast cancer recurrence risks: study
fiercebiotech • Dec 06, 2024
Caris Life Sciences and COTA, Inc. Announce Collaboration to Expand Collective Multi-Modal Data Offering
prnewswire • Jun 04, 2024
Noel Alaka on LinkedIn: If you're attending ISPOR today and work in hematology/oncology, be sure…
linkedin • Jun 04, 2024
Varian Medical Systems Invests in COTA, Inc. to Help Drive Faster, More Accurate Data-Driven Cancer Care
prnewswire • Nov 10, 2020
Study of NSCLC, melanoma outcomes points to surrogacy between real-world endpoints and clinical trial endpoints
cancerletter • Nov 10, 2020
Investors in Cota Healthcare
Discover investors in Cota Healthcare stock and explore their portfolio companies
Cota Healthcare Management
Leadership team at Cota Healthcare
Chief Executive Officer
Michael Doyle
Chief Medical Officer
Andrew Norden
Join now and verify your accreditation status to gain access to:
- Cota Healthcare current valuation
- Cota Healthcare stock price
- Available deals in Cota Healthcare and all other companies
- Deal offering documents
- EquityZen's proprietary data and insights, including
- Cap tables, which include funding history by Share Class and Liquidity Preferences
- Company Highlights
- Business Model
- Risk Factors
Trading Cota Healthcare Stock
How to invest in Cota Healthcare stock?
Accredited investors can buy pre-IPO stock in companies like Cota Healthcare through EquityZen funds. These investments are made available by existing Cota Healthcare shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.
How to sell Cota Healthcare stock?
Shareholders can sell their Cota Healthcare stock through EquityZen's private company marketplace. EquityZen's network includes over 330K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 43K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."
